Skip to main content

National Conference on Quality and Safety of Biosimilars : Strengthening India's Biopharma SHAKTI Vision Organized by IPC

National Conference on Quality and Safety of Biosimilars : Strengthening India's Biopharma SHAKTI Vision Organized by IPC

The Indian Pharmacopoeia Commission (IPC) has been established as an autonomous Institution under the Ministry of Health & Family Welfare, Govt. of India primarily with the objectives of regularly updating the Indian Pharmacopoeia (an official book for setting standards of drugs in the Country) by publishing new edition and its addenda, National Formulary of India (reference book for rational use of generic medicines) and carrying out other related tasks such as providing Reference Substances to the stakeholders and conducting skill development programmes. The Commission also functions as National Coordination Centres (NCC) for Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI) for ensuring safety of drugs and medical devices, respectively, in the Country.

National Conference
Quality and Safety of Biosimilars: Strengthening India's Biopharma SHAKTI Vision

10th - 11th September, 2026 | 09:00 am - 05:00 pm
Centre for Cellular and Molecular Platforms, 
Dasheri Auditorium, NCBS-TIFR campus on Bellary Road,
GKVK Post, Bengaluru, 560065
Organized by 
Indian Pharmacopoeia Commission, Ghaziabad 
in technical collaboration with Indian Drug Manufacturers' Association

Expert Speakers from
• Indian Pharmacopoeia Commission 
• Drug Regulatory Authority 
• DBT-BIRAC
• Indian Drug Manufacturers Association/Industry 
• Centre for Cellular and Molecular Platforms 
• Scientist from Biosimilar Industry 
• Scientist from leading academic institutions
• Pharmacovigilance experts

Topic
• Pharmacopoeial standards for Biosimilars
• Development and Characterization of Biosimilars
• Biotherapeutics: Regulatory landscape
• Next Generation Biotherapeutics
• Pharmacovigilance of Biosimilars

Who should attend?
• Manufacturing & Process Development Teams (Biologics/Biosimilars)
• Scientists & R&D Professionals
• QC/QA Professionals
• Regulatory Professionals & Drug Regulatory Officials
• Academia & Researchers in the area of Biosimilar
• Pharmacovigilance & Drug Safety Professionals
• Signal Detection & Case Processing Professionals
• MSME


Registration Fee
For Academia & Research Scholars : Rs. 2500/- (Plus 18% GST)
For Industry Professionals : Rs. 5000/- (Plus 18% GST)

Registration Deadline : August 18, 2026

For Academia & Research Scholars : Register here

For Industry Professionals : Register here